Ginkgo Bioworks Completes Acquisition of Zymergen

/PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that Ginkgo has...

Related Keywords

Boston ,Massachusetts ,United States ,Jason Kelly ,Securities Exchange ,Nasdaq ,Ginkgo Bioworks ,Ginkgo Class ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,